Table 4.
Incubation of E6 cells with 4 -OHE2 alone or in presence of NAcCys1
| 4-OHE2 alone | 4-OHE2: NAcCys (1:0.5) | 4-OHE2: NAcCys (1:1) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected Compounds2 | 1 | 10 | 30 | 1 | 10 | 30 | 1 | 10 | 30 |
| pmol/10 million cells | |||||||||
| 4-OHE1(E2) | 1.29 ± 0.11 |
4.46 ± 1.01 |
20.1 ± 1.76 |
0.78 ± 0.09 |
2.86 ± 0.86 |
10.5 ± 2.40 |
0.21 ± 0.07 |
0.59 ± 0.10 |
3.56 ± 1.13 |
| 4-OCH3E1(E2) | 2077 ± 327 |
4669 ± 440 |
15112 ± 1652 |
2377 ± 338 |
5718* ± 342 |
19804* ± 1325 |
2785* ± 335 |
7599* ± 963 |
36372* ± 3355 |
| 4-OHE1(E2)-2-SG | 2.38 ± 0.47 |
13.9 ± 2.02 |
33.0 ± 4.19 |
2.67 ± 0.55 |
16.4 ± 0.57 |
40.8* ± 1.70 |
3.07 ± 0.70 |
18.6* ± 2.32 |
50.4* ± 3.23 |
| 4-OHE1(E2)-2-Cys | 6.19 ± 1.29 |
18.12 ± 2.53 |
38.5 ± 7.06 |
7.25 ± 1.16 |
22.3* ± 2.27 |
50.4 ± 7.53 |
8.80 ± 1.81 |
28.4* ± 2.92 |
64.2* ± 7.61 |
| 4-OHE1(E2)-2-NAcCys | 6.22 ± 0.66 |
17.9 ± 1.53 |
40.5 ± 6.46 |
7.23 ± 0.96 |
22.1* ± 1.92 |
54.3* ± 6.82 |
8.78* ± 1.07 |
26.8* ± 2.04 |
70.8* ± 11.9 |
| 4-OHE1(E2)-1-N3Ade | 1.33 ± 0.28 |
4.18 ± 0.87 |
41.9 ± 4.97 |
1.07 ± 0.05 |
2.81* ± 0.33 |
25.3* ± 1.88 |
0.53* ± 0.03 |
1.63* ± 0.26 |
4.00* ± 0.73 |
| 4-OHE1(E2)-1-N7Gua | 0.97 ± 0.11 |
3.97 ± 0.59 |
39.6 ± 4.65 |
0.79* ± 0.09 |
2.70* ± 0.51 |
24.3* ± 1.48 |
0.51* ± 0.04 |
1.58* ± 0.25 |
4.59* ± 0.83 |
E6 cells were incubated at 37 °C for 24 h with 4-OHE2 (1, 10 or 30 µM) alone or in the presence of different ratios of NAcCys.
The compounds were identified and quantified by HPLC-ECD and the adducts were confirmed by UPLC-MS/MS; values are an average of three replicates from three independent pools of medium each from a set of five flasks; ± standard deviation.
The value is significantly different from th at in the cell s not treated with NAcCys (p<0.05) as determined by the t-test.